Is Semax or Selank FDA approved
Patient overlap: In a clinical setting, these tools are not either/or
Therapies targeting endothelial dysfunction, such as phosphodiesterase-5 inhibitors and endothelin receptor antagonists, have shown efficacy in improving hemodynamics and symptoms in PAH patients ( Inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-), and monocyte chemoattractant protein-1 (MCP-1) are elevated in PAH, contributing to endothelial damage and vascular remodeling ( Oxidative stress plays a critical role in the pathogenesis of PAH, primarily through its effects on endothelial dysfunction, vascular remodeling, and cellular metabolic reprogramming
Heiby , Mariaelena Pierbon, Barbara Merritt, Joel Sennesh, Lucia Pastore, Kirsten Edmiston, Emanuel F